However, concerning ApoA1, an increase in alcohol consumption would have been associated with an increase in ApoA1 [50,51] in the “NAFLD-Serum” cohort, which included 78% of subjects without advanced fibrosis [9]. This evidence concerns the gene APOA1 and metabolic dysfunction-associated steatotic liver disease.